ADA Scientific Sessions 2026 Abstract · Jun 5, 2026
Routine Blood Biomarkers Predict Five-Year Risk of Type 2 Diabetes in Adults without Diabetes
By TANG S, CAI F, NYHOLT D
Introduction and Objective: Type 2 diabetes (T2D) often develops silently over years, making early risk identification critical for prevention. This study aimed to determine whether routine blood biomarkers can predict 5-year T2D risk in adults without diabetes. Methods: We analyzed de-identified blood diagnostic data from 80,000 adults without diabetes, defined as HbA1c <6.0% or fasting glucose < 6.1 mmol/L in Ontario, Canada (2014-2025). Only blood biomarker data were used, therefore this population could also include individuals with well-controlled diabetes. Participants were aged ≥18 years and had all required biomarkers measured in the same visit: HbA1c, fasting glucose, lipid profile, creatinine, and CBC. Age and sex were included as covariates and individuals also had to have sufficient data to calculate at least one of these insulin resistance indexes: HOMA-IR, TG/HDL-C ratio, Triglyceride/Glucose (TyG) index. A Random Survival Forest (RSF) model was developed to predict time to incident prediabetes (HbA1c ≥6.0% or 2-hour OGTT ≥7.8 mmol/L) over 5 years. Results: In the validation cohort, the RSF model demonstrated strong discrimination (C-index: 0.84 [95% CI 0.83-0.84]; 5-year time-dependent AUC: 0.87 [95% CI 0.87-0.88]) and calibration (5-year Integrated Brier Score: 0.050 [95% CI 0.049-0.051]). After adjusting for age, sex and HbA1C, stratification by predicted risk quantiles showed effective separation, with significantly elevated progression risk in high (HR 4.06 [95% CI 3.47-4.75]) and medium (HR 2.31 [95% CI 2.01-2.67]) versus low quantile. Conclusion: Routine blood biomarkers can predict future T2D risk in adults without diabetes. The RSF approach demonstrated strong predictive performance highlighting its potential for integration into routine screening to enable early intervention. Disclosure: S. Tang: Employee; Current; LifeLabs. F. Cai: Employee; Current; LifeLabs. D. Nyholt: Employee; Current; LifeLabs.